The Global Clinical Trial Management Systems Market Is Projected To Garner A Valuation Of Around US$ 1.3 Bn In 2022

Clinical Trial Management Systems By Mode of Deployment (Cloud-based, Web-based, On-premise), By Component (Hardware, Software, Services), By Product Type (Enterprise-based, Site-based), By End User, By Region - Global Insights 2022-2032


ROCKVILLE, Md., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Deployment of clinical trial management systems are slated to accelerate at a high CAGR of 13.6% to top US$ 4.6 Bn by 2032. Demand for web-based clinical trial management systems is expected to witness expansion at a CAGR of 13.9%.

As per a recent published report by Fact.MR, a market research and competitive intelligence provider, the global clinical trial management systems market is anticipated to close in on a valuation of US$ 1.3 Bn in 2022. Fact.MR anticipates significant potential in the market, due to increase in use of software.

The market registered an annual growth of 10.2% during 2017-2021. Fact.MR anticipates significant potential in the market, due to increase in use of software.

“Preference for enterprise-based clinical trial management systems can be gauged by the fact that this segment accounted for nearly three-fourth revenue share of the market in 2020,” says a Fact.MR analyst.

The global healthcare IT market was valued at around US$ 210 Bn in 2020, in which, clinical trial management (CTM) systems held a market share of 0.5%. Increasing investments by biotechnology and pharmaceutical companies coupled with funding from government is endorsing research activities. This factor is anticipated to boost growth of the market for clinical trial management systems 3.6x by 2032.

To gauge the scope of customization in our reports Ask for a Sample at https://www.factmr.com/connectus/sample?flag=S&rep_id=832

The software-based component and flexibility in terms of pricing and licensing are among the key evolutions in clinical trial management systems. Increasing complexity in clinical trials has meant that pharmaceutical companies prefer outsourcing clinical trial execution to contract organizations. The market value is likely to top a valuation of US$ 4.6 Bn by 2032 owing to high digitalization and internet penetration.

Competitive Landscape

Majority of companies are focused on expansions, investments, acquisitions, delivery, portfolio expansion, and brand development. Key players also have a strong position in the global market with a large set of customers, which springs them with an edge over their competitors in the market.

  • In October 2021, Parexel, a worldwide renowned clinical research organization and Kyoto University Hospital announced a collaboration for offering significant opportunities for clinical research and developing efficient methods of supporting clinical studies.
  • In December 2020, Oracle Corporation and Cerner Corporation announced an agreement for Oracle to acquire Cerner an all-cash tender offer for approximately USD 28.3 Bn in equity value.

Revenue Analysis of Clinical Trial Management Systems from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

  • North America is a lucrative region in the global market owing to the increasing demand for clinical trial management system in the U.S., which is anticipated to expand at a CAGR of 13% through 2032.
  • South Asia & Oceania achieved a market value of around US$ 185 Mn in 2021 owing to high rate of technology adoption.
  • East Asia and Europe made remarkable contributions to the development of clinical trial management systems, and accounted for nearly 17% and 26% market share in 2021, respectively.

Looking for Regional Analysis or Competitive Landscape in clinical trial management system market for Performance OEM, ask for a customized report https://www.factmr.com/connectus/sample?flag=RC&rep_id=832

Key Segments Covered in Clinical Trial Management System Industry Survey

By Mode of Deployment :

  • Cloud-based Clinical Trial Management Systems
  • Web-based Clinical Trial Management Systems
  • On-premise Clinical Trial Management Systems

By Component :

  • Clinical Trial Management System Hardware
  • Clinical Trial Management System Services
  • Clinical Trial Management System Software

By Product Type :

  • Enterprise-based Clinical Trial Management Systems
  • Site-based Clinical Trial Management Systems

By End User :

  • Pharmaceuticals
  • Clinical Research Organizations (CROs)
  • Healthcare Providers

Country-wise Analysis of Clinical Trial Management Systems:

The U.S. is likely to dominate the North America clinical trial management systems market with an estimated market share of more than 85% in 2022. Steady growth of pharmaceutical companies, clinical research organizations, and healthcare organizations, coupled with surge in investments in technical innovation, is supporting growth of the U.S. market.

The Germany market is estimated for a valuation of more than US$ 60 Mn in 2022. Factors such as increasing investments in research & development with rise in demand for the development of drugs are sustaining the growth of the market.

The market in East Asia valued at US$ 240 Mn in 2021. The region is expected to hold significant market opportunities owing to the growing investment by the governments of various countries for the advancement of clinical trials.

To get to know more about the short-term and long-term impact of COVID-19 on this Clinical Trial Management Systems Market,

Please Visit: https://www.factmr.com/media-release/501/clinical-trial-management-systems-market

Key Takeaways from Market Study

  • Cloud-based mode of deployment is likely to witness sales of over US$ 1 Bn by 2032.
  • Based on component, the hardware and services segments are likely to have a market share of 5.1% and 11.7% in 2032, respectively
  • Based on region, demand for clinical trial management systems is expected to expand at a CAGR of 15.3% and 12.7% in South Asia & Oceania and Europe, respectively, over the forecast period.
  • Together, North America and Europe represented over 60% of overall market share in 2022.
  • The market in East Asia is valued at US$ 240 Mn in 2022.

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the global clinical trial management system market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights by mode of deployment (cloud-based, web-based, and on-premise), component (hardware, services, and software), product type (enterprise-based and site-based), and end user (pharmaceuticals, clinical research organizations, and healthcare providers), across six major regions of the world (North America, Latin America, Europe, East Asia, South Asia & Oceania, and the Middle East & Africa).

To understand how our report can bring difference to your business strategy, Purchase a copy of this report at https://www.factmr.com/checkout/832

Check out more studies related to Technology Industry, conducted by Fact.MR:

Escalating number of Security Breaches, Cyberattacks Driving Market Demand - Increasing number of data breaches and data leakages is fueling the market demand and growth of the intrusion detection & protection systems market by 1.3X during forecast years of 2022-2032.

Global Clientless Remote Support Software Market Outlook - The global clientless remote support software market is estimated at USD 1.7 Billion in 2022 and is forecast to surpass USD 6.7 Billion by 2032, growing at a CAGR of 14.5% from 2022 to 2032.

Demand Analysis of Peer-to-Peer Electric Vehicle Charging Market Projections for 2022 to 2032 -

As the world increasingly moves towards electric mobility, the number of EVs is bound to rise prolifically, hence the need for instant charging points is rising. This is providing traction to the market for peer-to-peer EV chargers.

Country-wise Analysis of Mobile Payments Market - Changing lifestyle along with latest online retailing trends in countries like India and China is playing a key role in an increase in the use of mobile payments.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

Mahendra Singh

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Tel: +1 (628) 251-1583